维生素D缺乏与日本2岁男孩的神经发育问题相关
Kahoko Yasumitsu-Lovell1,2,3, Lucy Thompson1,2,4, Elisabeth Fernell1,2
1Gillberg Neuropsychiatry Centre, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Acta paediatrica (Oslo, Norway : 1992)
|October 20, 2023
概括
维生素D缺乏与年轻男孩的神经发育问题有关,但与女孩无关. 这项研究强调了维生素D如何影响儿童发育的潜在性别差异.
科学领域:
- 儿科健康 儿科健康
- 神经发育障碍 神经发育障碍
- 营养科学 营养科学
背景情况:
- 建议维生素D缺乏与神经发育障碍 (NDP) 之间存在关联,但一般人群的大规模研究有限.
- 研究这些关联中的性别差异对于理解儿童发育至关重要.
研究的目的:
- 检查血清25-氧维生素D (25(OH) D水平与儿童神经发育问题 (NDPs) 之间的关联.
- 探索维生素D状态与NDPs之间的关系中的潜在性别差异.
主要方法:
- 血清25 ((OH) D和NDPs在日本环境和儿童研究的子队列中在两岁时被评估.
- 使用2001年京都心理发展量表来评估NDP,调整后的几率比率计算在70以下的发育系数得分上.
主要成果:
- 与女孩相比,男孩的25...OH) D水平较高,但京都尺度得分较低.
- 男孩的维生素D缺乏与较低的整体发育系数 (aOR=2.33),认知适应性得分 (aOR=1.91) 和语言社会得分 (aOR=1.69) 有关.
- 对于女孩的结果是不确定的,没有明确的关联.
结论:
- 维生素D缺乏与神经发育问题之间显著的关联仅在男孩身上被观察到.
- 研究结果表明,维生素D对幼儿时代神经发育的潜在性别特异性影响.
更多相关视频
相关概念视频
Vitamins
745
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
745
Attention-Deficit/Hyperactivity Disorder
73
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
73
Intellectual Disability
57
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
57
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
318
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
318


